Boston Scientific Corp (BSX) concluded trading on Wednesday at a closing price of $90.84, with 3.49 million shares of worth about $316.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.70% during that period and on December 04, 2024 the price saw a gain of about 0.41%. Currently the company’s common shares owned by public are about 1.47B shares, out of which, 1.47B shares are available for trading.
Stock saw a price change of 0.70% in past 5 days and over the past one month there was a price change of 7.22%. Year-to-date (YTD), BSX shares are showing a performance of 57.14% which increased to 65.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $53.93 but also hit the highest price of $91.93 during that period. The average intraday trading volume for Boston Scientific Corp shares is 5.89 million. The stock is currently trading 1.66% above its 20-day simple moving average (SMA20), while that difference is up 4.45% for SMA50 and it goes to 17.33% higher than SMA200.
Boston Scientific Corp (NYSE: BSX) currently have 1.47B outstanding shares and institutions hold larger chunk of about 91.35% of that.
The stock has a current market capitalization of $133.88B and its 3Y-monthly beta is at 0.80. PE ratio of stock for trailing 12 months is 75.14, while it has posted earnings per share of $1.21 in the same period. Its PEG reads 5.29 and has Quick Ratio of 1.02 while making debt-to-equity ratio of 0.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BSX, volatility over the week remained 1.33% while standing at 1.76% over the month.
Stock’s fiscal year EPS is expected to rise by 20.04% while it is estimated to increase by 13.35% in next year. EPS is likely to grow at an annualized rate of 14.20% for next 5-years, compared to annual growth of -2.05% made by the stock over the past 5-years.
Coverage by Goldman stated Boston Scientific Corp (BSX) stock as a Buy in their note to investors on May 30, 2024, suggesting a price target of $90 for the stock. On February 01, 2024, Mizuho Upgrade their recommendations, while on July 19, 2023, Robert W. Baird Initiated their ratings for the stock with a price target of $59. Stock get a Buy rating from CL King on June 30, 2023.
